Anti-GL6D1/ GLT6D1/ GLTDC1 functional antibody

Anti-GL6D1/ GLT6D1/ GLTDC1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GLT6D1/GLT6D1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1652-Ab-1/ GM-Tg-hg-SE1652-Ab-2Anti-Human GLT6D1 monoclonal antibodyHuman
GM-Tg-rg-SE1652-Ab-1/ GM-Tg-rg-SE1652-Ab-2Anti-Rat GLT6D1 monoclonal antibodyRat
GM-Tg-mg-SE1652-Ab-1/ GM-Tg-mg-SE1652-Ab-2Anti-Mouse GLT6D1 monoclonal antibodyMouse
GM-Tg-cynog-SE1652-Ab-1/ GM-Tg-cynog-SE1652-Ab-2Anti-Cynomolgus/ Rhesus macaque GLT6D1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1652-Ab-1/ GM-Tg-felg-SE1652-Ab-2Anti-Feline GLT6D1 monoclonal antibodyFeline
GM-Tg-cang-SE1652-Ab-1/ GM-Tg-cang-SE1652-Ab-2Anti-Canine GLT6D1 monoclonal antibodyCanine
GM-Tg-bovg-SE1652-Ab-1/ GM-Tg-bovg-SE1652-Ab-2Anti-Bovine GLT6D1 monoclonal antibodyBovine
GM-Tg-equg-SE1652-Ab-1/ GM-Tg-equg-SE1652-Ab-2Anti-Equine GLT6D1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-SE1652-Ab-1/ GM-Tg-hg-SE1652-Ab-2; GM-Tg-rg-SE1652-Ab-1/ GM-Tg-rg-SE1652-Ab-2;
GM-Tg-mg-SE1652-Ab-1/ GM-Tg-mg-SE1652-Ab-2; GM-Tg-cynog-SE1652-Ab-1/ GM-Tg-cynog-SE1652-Ab-2;
GM-Tg-felg-SE1652-Ab-1/ GM-Tg-felg-SE1652-Ab-2; GM-Tg-cang-SE1652-Ab-1/ GM-Tg-cang-SE1652-Ab-2;
GM-Tg-bovg-SE1652-Ab-1/ GM-Tg-bovg-SE1652-Ab-2; GM-Tg-equg-SE1652-Ab-1/ GM-Tg-equg-SE1652-Ab-2
Products NameAnti-GLT6D1 monoclonal antibody
Target NameGLT6D1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-GLT6D1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1652-Ag-1Recombinant multi-species GL6D1/ GLT6D1/ GLTDC1 protein

    Target information

    Target IDGM-SE1652
    Target NameGLT6D1
    Gene ID360203,71103,296577,711729,491262,101090658,529958,100068354
    Gene Symbol and Synonyms4933411C14Rik,GLT6D1,GLTDC1,GT6M7
    Uniprot AccessionQ7Z4J2,D3ZNQ3,Q2YDM8
    Uniprot Entry NameGL6D1_HUMAN,GL6D1_RAT,GL6D1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Gene EnsemblENSG00000204007
    Target ClassificationN/A

    The target: GLT6D1, gene name: GLT6D1, also named as GLTDC1, GT6M7. The GT6 glycosyltransferases gene family, which includes the ABO blood group (ABO; MIM 110300) and GLT6D1, shows a complex evolution pattern, with multiple events of gain and loss in different mammal species. In humans, the ABO gene is considered the sole functional member, although the O allele is null and is fixed in certain populations (summary by Casals et al. (2009) [PubMed 19218399]).[supplied by OMIM, Jan 2011].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.